The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Rapid induction of Alzheimer A beta amyloid formation by zinc
Abstract
A beta 1-40, a major component of Alzheimer's disease cerebral amyloid, is present in the cerebrospinal fluid and remains relatively soluble at high concentrations (less than or equal to 3.7 mM). Thus, physiological factors which induce A beta amyloid formation could provide clues to the pathogenesis of the disease. It has been shown that human A beta specifically and saturably binds zinc. Here, concentrations of zinc above 300 nM rapidly destabilized human A beta 1-40 solutions, inducing tinctorial amyloid formation. However, rat A beta 1-40 binds zinc less avidly and is immune to these effects, perhaps explaining the scarcity with which these animals form cerebral A beta amyloid. These data suggest a role for cerebral zinc metabolism in the neuropathogenesis of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, it was shown that that metal ions promote Aβ aggregation,16,17 as well as formation of reactive oxygen species (ROS) and lead to oxidative stress.18–20”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [16]
In the citing paper
“Several studies showed that Zn2+ promotes formation of nonfibrillar aggregates,16,29–31 yet conflicting results have been reported for the Cu2+-mediated Aβ aggregation.”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [16]
In the citing paper
“These metal ions have been shown to affect Aβ aggregation, as well as lead to the formation of reactive oxygen species (ROS).12−16”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [12]
Citations
Cites
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citationJarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Amyloid Deposits and Amyloidosis
Glenner, G. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006053022305 · Cited by 1,780
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Mutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I. M., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,399
Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,001
Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals
Berti, V., Murray, J., Davies, M., Spector, N. C., Tsui, W. H., Li, Y., Williams, S. K., Pirraglia, E., Vallabhajosula, S., McHugh, P. F., et al. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0534-0 · Cited by 156
Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 155
Harris, F. M., Brecht, W. J., Xu, Q., Mahley, R. W., & Huang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408127200 · Cited by 151
Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 154
Reaume, A. G., Howland, D. S., Trusko, S. P., Savage, M. J., Lang, D. M., Greenberg, B. D., Siman, R., & Scott, R. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23380 · Cited by 150
Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder
Yoon, S. H., Choi, J., Lee, W. Y., & Do, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040966 · Cited by 175
Aqueous Fluorescence Turn-on Sensor for Zn2+ with a Tetraphenylethylene Compound
Sun, F., Zhang, G., Zhang, D., Xue, L., & Jiang, H. (2011) · Organic Letters · doi:10.1021/ol2026735 · Cited by 149
Modulating Amyloid Self-Assembly and Fibril Morphology with Zn(II)
Dong, J., Shokes, J. E., Scott, R. A., & Lynn, D. G. (2006) · Journal of the American Chemical Society · doi:10.1021/ja055973j · Cited by 149
The Role of Zinc in Alzheimer′s Disease
Watt, N. T., Whitehouse, I. J., & Hooper, N. M. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/971021 · Cited by 148
Liu, G., Men, P., Kudo, W., Perry, G., & Smith, M. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.064 · Cited by 148
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
Unzeta, M., Esteban, G., Bolea, I., Fogel, W. A., Ramsay, R. R., Youdim, M. B. H., Tipton, K. F., & Marco, J. L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00205 · Cited by 154
Oxidative processes in Alzheimer's disease: the role of Aβ-metal interactions
Lynch, T. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00112-1 · Cited by 151
Binding of Zn(II), Cu(II), and Fe(II) ions to alzheimer's Aß peptide studied by fluorescence
Garzon-Rodriguez, W., Yatsimirsky, A. K., & Glabe, C. G. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00357-1 · Cited by 148
Impact of antioxidants, zinc, and copper on cognition in the elderly
Age-Related Eye Disease Study Research Group (2004) · Neurology · doi:10.1212/01.wnl.0000142969.19465.8f · Cited by 149
Transgenic mouse models of Alzheimer's disease: phenotype and application.
(2003) · PubMed · doi:10.1097/01.fbp.0000088420.18414.ff · Cited by 147
Alzheimer's disease & metals: therapeutic opportunities
Kenche, V. B., & Barnham, K. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01221.x · Cited by 147
Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium
Isaacs, A. M., Senn, D. B., Yuan, M., Shine, J. P., & Yankner, B. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602061200 · Cited by 149
Whitfield, D., Vallortigara, J., Alghamdi, A., Howlett, D. R., Hortobágyi, T., Johnson, M., Attems, J., Newhouse, S., Ballard, C. G., Thomas, A. J., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.015 · Cited by 144
Masters, C. L., & Beyreuther, K. (2006) · Brain · doi:10.1093/brain/awl251 · Cited by 145
Self-citationKaruppagounder, S. S., Xu, H., Shi, Q., Chen, L. H., Pedrini, S., Pechman, D., Baker, H., Beal, M. F., Gandy, S., & Gibson, G. E. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.013 · Cited by 144
Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis
Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.016 · Cited by 141
Self-citationPrion protein facilitates uptake of zinc into neuronal cells
Watt, N. T., Taylor, D. R., Kerrigan, T. L., Jarosz-Griffiths, H., Rushworth, J. V., Whitehouse, I. J., & Hooper, N. M. (2012) · Nature Communications · doi:10.1038/ncomms2135 · Cited by 137
Friedlich, A. L., Lee, J., van Groen, T., Cherny, R. A., Volitakis, I., Cole, T. B., Palmiter, R. D., Koh, J., & Bush, A. I. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0297-04.2004 · Cited by 138
Self-citationBlood cadmium levels and Alzheimer’s disease mortality risk in older US adults
Min, J., & Min, K. (2016) · Environmental Health · doi:10.1186/s12940-016-0155-7 · Cited by 138
Golabek, A. A., Soto, C. A., Vogel, T., & Wısnıewskı, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10602 · Cited by 137
Lalowski, M. M., Golabek, A. A., Lemere, C. A., Selkoe, D. J., Wı́sniewski, H. M., Beavis, R. C., Frangione, B., & Wısnıewskı, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33623 · Cited by 134
Neuroprotective features of carnosine in oxidative driven diseases
Bellia, F., Vecchio, G., Cuzzocrea, S., Calabrese, V., & Rizzarelli, E. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.009 · Cited by 142
The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease
McCord, M. C., & Aizenman, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00077 · Cited by 142
James, S., Churches, Q. I., de Jonge, M. D., Birchall, I. E., Streltsov, V. A., McColl, G., Adlard, P. A., & Hare, D. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00362 · Cited by 136
Structure and function of amyloid in Alzheimer's disease
Morgan, C., Colombres, M., Núñez, M. T., & Inestrosa, N. C. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.004 · Cited by 146
Lee, J., Mook‐Jung, I., & Koh, J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-11-j0002.1999 · Cited by 136
The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity
Sharma, A. K., Pavlova, S. T., Kim, J., Kim, J., & Mirica, L. M. (2013) · Metallomics · doi:10.1039/c3mt00161j · Cited by 135
Guilloreau, L., Damian, L., Coppel, Y., Mazarguil, H., Winterhalter, M., & Faller, P. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0154-1 · Cited by 134
Metal exposure and Alzheimer’s pathogenesis
Liu, G., Huang, W., Moir, R. D., Vanderburg, C. R., Lai, B. C. H., Peng, Z., Tanzi, R. E., Rogers, J. T., & Huang, X. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.12.011 · Cited by 135
Self-citationKwon, J. E., Lee, S., You, Y., Baek, K.-H., Ohkubo, K., Cho, J., Fukuzumi, S., Shin, I., Park, S. Y., & Nam, W. (2012) · Inorganic Chemistry · doi:10.1021/ic300476e · Cited by 134
Zinc, Carnosine, and Neurodegenerative Diseases
Kawahara, M., Tanaka, K.-I., & Kato-Negishi, M. (2018) · Nutrients · doi:10.3390/nu10020147 · Cited by 134
Amyloid accomplices and enforcers
Alexandrescu, A. T. (2004) · Protein Science · doi:10.1110/ps.04887005 · Cited by 137
Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity
Dong, J., Canfield, J. M., Mehta, A. K., Shokes, J. E., Tian, B., Childers, W. S., Simmons, J. A., Mao, Z., Scott, R. A., Warncke, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702669104 · Cited by 134
Awasthi, M., Singh, S., Pandey, V. P., & Dwivedi, U. N. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.01.008 · Cited by 139
Zinc-binding structure of a catalytic amyloid from solid-state NMR
Lee, M., Wang, T., Makhlynets, O. V., Wu, Y., Polizzi, N. F., Wu, H., Gosavi, P. M., Stöhr, J., Korendovych, I. V., DeGrado, W. F., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706179114 · Cited by 133
Ikeda, K., Okada, T., Sawada, S., Akiyoshi, K., & Matsuzaki, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.009 · Cited by 133
Lithium deficiency and the onset of Alzheimer’s disease
Aron, L., Ngian, Z., Qiu, C., Choi, J., Liang, M., Drake, D., Hamplova, S. E., Lacey, E. K., Roche, P., Yuan, M., et al. (2025) · Nature · doi:10.1038/s41586-025-09335-x · Cited by 153
Zinc in the Brain: Friend or Foe?
Choi, S., Hong, D. K., Choi, B. Y., & Suh, S. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238941 · Cited by 140
Zinc Binding to Alzheimer's Aβ(1–16) Peptide Results in Stable Soluble Complex
Kozin, S. A., Zirah, S., Rebuffat, S., Hoa, G. H. B., & Debey, P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5284 · Cited by 131
Disease-modifying treatments for Alzheimer’s disease
Galimberti, D., & Scarpini, E. A. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611404470 · Cited by 128
Biometals and Their Therapeutic Implications in Alzheimer's Disease
Ayton, S., Lei, P., & Bush, A. I. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0312-z · Cited by 134
Self-citationA Highly Selective Chemosensor for Al(III) and Zn(II) and Its Coordination with Metal Ions
Cao, W., Zheng, X., Sun, J.-P., Wong, W., Fang, D., Zhang, J., & Jin, L. (2014) · Inorganic Chemistry · doi:10.1021/ic402811x · Cited by 130
Zinc: indications in brain disorders
Prakash, A. K., Bharti, K., & Majeed, A. B. A. (2015) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12110 · Cited by 131
Formation of Bradykinin: A Major Contributor to the Innate Inflammatory Response
Joseph, K., & Kaplan, A. P. (2005) · Advances in immunology · doi:10.1016/s0065-2776(04)86005-x · Cited by 129
Grossi, C., Francese, S., Casini, A., Rosi, M. C., Luccarini, I., Fiorentini, A., Gabbiani, C., Luigi Messori, A., Moneti, G., & Casamenti, F. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1063 · Cited by 131
Copper, β-amyloid, and Alzheimer's disease: Tapping a sensitive connection
Bush, A. I., Masters, C. L., & Tanzi, R. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135061100 · Cited by 128
Self-citationMetal protein attenuating compounds for the treatment of Alzheimer's dementia
Sampson, E. L., Jenagaratnam, L., & McShane, R. H. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005380.pub5 · Cited by 128
Signal transduction during amyloid-β-peptide neurotoxicity: role in Alzheimer disease
Fuentealba, R. A., Farı́as, G. G., Scheu, J., Bronfman, M., Marzolo, M., & Inestrosa, N. C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.018 · Cited by 126
Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases
Breydo, L., & Uversky, V. N. (2011) · Metallomics · doi:10.1039/c1mt00106j · Cited by 129
Uddin, M. S., Kabir, M. T., Rahman, M. S., Behl, T., Jeandet, P., Ashraf, G. M., Najda, A., Bin-Jumah, M. N., El-Seedi, H. R., & Abdel‐Daim, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165858 · Cited by 131
Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease
Leskovjan, A. C., Lanzirotti, A., & Miller, L. M. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.063 · Cited by 129
Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
Abelein, A., Gräslund, A., & Danielsson, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421961112 · Cited by 123
Therapeutic Redistribution of Metal Ions To Treat Alzheimer’s Disease
Crouch, P. J., & Barnham, K. J. (2012) · Accounts of Chemical Research · doi:10.1021/ar300074t · Cited by 125
Alzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123
Geng, J., Li, M., Wu, L., Chen, C., & Qu, X. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200067 · Cited by 124
Transient receptor potential channels in Alzheimer's disease
Yamamoto, S., Wajima, T., Hara, Y., Nishida, M., & Mori, Y. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.03.006 · Cited by 127
Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments
Fraser, S. P., Suh, Y.-H., & Djamgoz, M. B. A. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10079-5 · Cited by 127
Koh, J. (2001) · Molecular Neurobiology · doi:10.1385/mn:24:1-3:099 · Cited by 124
Xiong, Y., Jing, X.-P., Zhou, X.-W., Wang, X.-L., Yang, Y., Sun, X.-Y., Qiu, M., Cao, F.-Y., Lu, Y.-M., Liu, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.003 · Cited by 122
Rodent Aβ Modulates the Solubility and Distribution of Amyloid Deposits in Transgenic Mice
Jankowsky, J. L., Younkin, L. H., Gonzales, V., Fadale, D. J., Slunt, H. H., Lester, H. A., Younkin, S. G., & Borchelt, D. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611050200 · Cited by 122
Metal imaging in neurodegenerative diseases
Bourassa, M. W., & Miller, L. M. (2012) · Metallomics · doi:10.1039/c2mt20052j · Cited by 125
Ghribi, O., Golovko, M. Y., Larsen, B., Schrag, M., & Murphy, E. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04079.x · Cited by 97
RetractedCu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β Peptides
Pedersen, J. T., Østergaard, J., Rozlosnik, N., Gammelgaard, B., & Heegaard, N. H. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220863 · Cited by 123
Metal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease
Wang, P., & Wang, Z. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.003 · Cited by 123
The galvanization of β-amyloid in Alzheimer's disease
Bush, A. I., & Tanzi, R. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249699 · Cited by 122
Self-citationCurrent therapeutic targets for the treatment of Alzheimer’s disease
Grill, J. D., & Cummings, J. L. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.29 · Cited by 123
González, G., Martín, M., Cacho, Breñas, Arroyo, García‐Berrocal, Navajo, & González‐Buitrago (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00471.x · Cited by 120
Zinc, human diseases and aging
Fabris, Ν., & Mocchegiani, E. (1995) · Aging Clinical and Experimental Research · doi:10.1007/bf03324297 · Cited by 123
Simons, M., Ikonen, E., Tienari, P. J., Arregui, A. C., Mönning, U., Beyreuther, K. T., & Dotti, C. G. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410114 · Cited by 123
Self-citationHe, W., Luo, L., Liu, Q., & Chen, Z. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00076 · Cited by 119
Nazıroğlu, M., Muhamad, S., & Pecze, L. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1324781 · Cited by 118
Copper, Zinc, and the Metallobiology of Alzheimer Disease
Bush, A. I. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200307000-00005 · Cited by 117
Self-citationJiang, L., Yao, T., Zhu, Z.-L., Wang, C., & Ji, L. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.014 · Cited by 117
Characterization of metal profiles in serum during the progression of Alzheimer's disease
González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2013) · Metallomics · doi:10.1039/c3mt00301a · Cited by 119
Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation
Hane, F. T., & Leonenko, Z. (2014) · Biomolecules · doi:10.3390/biom4010101 · Cited by 120
Chen, W.-T., Hong, C., Lin, Y.-T., Chang, W.-H., Huang, H.-T., Liao, J., Chang, Y.-J., Hsieh, Y.-F., Cheng, C.-Y., Liu, H.-C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035807 · Cited by 119
Soto, C. A., & Castaño, E. M. (1996) · Biochemical Journal · doi:10.1042/bj3140701 · Cited by 116
Bush, A. I., Pettingell, W. H., Paradis, M. D., Tanzi, R. E., & Wasco, W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47062-7 · Cited by 117
Self-citationChauhan, A., Ray, I., & Chauhan, V. P. S. (2000) · Neurochemical Research · doi:10.1023/a:1007509608440 · Cited by 117
Migliorini, C., Porciatti, E., Łuczkowski, M., & Valensin, D. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.07.004 · Cited by 117
Jiang, D., Rauda, I. E., Han, S., Chen, S., & Zhou, F. (2012) · Langmuir · doi:10.1021/la3021436 · Cited by 117
Elemental imbalances in the olfactory pathway in Alzheimer's disease
Samudralwar, D. L., Diprete, C. C., Ni, B. F., Ehmann, W. D., & Markesbery, W. R. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00018-w · Cited by 116
Jiang, L., Huang, X., Chen, D., Yan, H., Li, X., & Du, X. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611973 · Cited by 115
Okada, T., Wakabayashi, M., Ikeda, K., & Matsuzaki, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.069 · Cited by 116
Stoltenberg, M., Bush, A. I., Bach, G., Smidt, K., Larsen, A., Rungby, J., Lund, S. A., Doering, P., & Danscher, G. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.025 · Cited by 114
Self-citationNitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya
Cuajungco, M. P., & Lees, G. J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00463-6 · Cited by 116
Burdick, D., Kosmoski, J., Knauer, M. F., & Glabe, C. G. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01262-0 · Cited by 102
Progress in Alzheimer’s disease
Galimberti, D., & Scarpini, E. A. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6145-3 · Cited by 114
Liu, H., Liu, T., Li, J., Zhang, Y., Li, J., Song, J., Qu, J., & Wong, W. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01743c · Cited by 113
Examining the zinc binding site of the amyloid‐β peptide
Yang, D., McLaurin, J., Qin, K., Westaway, D. A., & Fraser, P. E. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01767.x · Cited by 113
Alzheimer's Disease, β-Amyloid Protein and Zinc
Huang, X., Cuajungco, M. P., Atwood, C., Moir, R. D., Tanzi, R. E., & Bush, A. I. (2000) · Journal of Nutrition · doi:10.1093/jn/130.5.1488s · Cited by 114
Self-citationXu, W., Ren, C., Teoh, C. L., Peng, J., Gadre, S. H., Rhee, H., Lee, C.-L. K., & Chang, Y. (2014) · Analytical Chemistry · doi:10.1021/ac501953z · Cited by 113
The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticals
Donnelly, P. S. (2011) · Dalton Transactions · doi:10.1039/c0dt01075h · Cited by 112
Wang, Z.-X., Tan, L., Wang, H.-F., Ma, J., Liu, J., Tan, M., Sun, J., Zhu, X., Jiang, T., & Yu, J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143108 · Cited by 112
Metadata
- Authors
- Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R.
- Affiliations
- Harvard University (US)
- Heidelberg University (DE)
- Mental Health Research Institute (AU)
- Venue
- Science
- Published
- 1994-09-02
- Volume
- 265
- Issue
- 5177
- Pages
- 1464-1467
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2094808560
- Cited by
- 1,522
- References
- 31
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 28 · 2023: 46 · 2022: 36 · 2021: 52 · 2020: 68 · 2019: 56 · 2018: 58 · 2017: 78 · 2016: 64 · 2015: 60 · 2014: 74 · 2013: 64 · 2012: 80
- FWCI
- 21.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag011899-03, 5r01ns030428-07)
- National Institute on Aging (R01 AG11899-01)
- National Institute of Neurological Disorders and Stroke (R01 NS30428-03)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- Alzheimer's disease, Aβ40, zinc binding, amyloid fibril formation, zinc metabolism, cerebrospinal fluid, neuropathogenesis
- MeSH terms
- Alzheimer Disease, Animals, Brain, Edetic Acid, Humans, Kinetics, Peptide Fragments, Solubility, Zinc, Amyloid beta-Peptides, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review